TY - JOUR
T1 - Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
AU - Radaev, Sergei
AU - Kattah, Michael
AU - Rostro, Bertha
AU - Colonna, Marco
AU - Sun, Peter D.
N1 - Funding Information:
We thank C. Hammer and M. Garfield for mass spectroscopy measurements and N-terminal amino acid sequencing; J. Johnson, Z. Dauter, and J. Chrzas for their help with X-ray synchrotron data collection; and J. Boyington and C. Foster for their valuable comments on the manuscript. The use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. W-31-109-Eng-38. This work is supported by the intramural research funding from the National Institute of Allergy and Infectious Diseases.
PY - 2003/12
Y1 - 2003/12
N2 - Triggering receptors expressed on myeloid cells (TREM) are a family of recently discovered receptors that play important roles in innate immune responses, such as to activate inflammatory responses and to contribute to septic shock in response to microbial-mediated infections. To date, two TREM receptors in human and several homologs in mice have been identified. We report the 2.6 Å resolution crystal structure of the extracellular domain of human TREM-1. The overall fold of the receptor resembles that of a V-type immunoglobulin domain with differences primarily located in the N-terminal strand. TREM-1 forms a "head-to-tail" dimer with 4100 Å 2 interface area that is partially mediated by a domain swapping between the first strands. This mode of dimer formation is different from the "head-to-head" dimerization that existed in VHV L domains of antibodies or V domains of T cell receptors. As a result, the dimeric TREM-1 most likely contains two distinct ligand binding sites.
AB - Triggering receptors expressed on myeloid cells (TREM) are a family of recently discovered receptors that play important roles in innate immune responses, such as to activate inflammatory responses and to contribute to septic shock in response to microbial-mediated infections. To date, two TREM receptors in human and several homologs in mice have been identified. We report the 2.6 Å resolution crystal structure of the extracellular domain of human TREM-1. The overall fold of the receptor resembles that of a V-type immunoglobulin domain with differences primarily located in the N-terminal strand. TREM-1 forms a "head-to-tail" dimer with 4100 Å 2 interface area that is partially mediated by a domain swapping between the first strands. This mode of dimer formation is different from the "head-to-head" dimerization that existed in VHV L domains of antibodies or V domains of T cell receptors. As a result, the dimeric TREM-1 most likely contains two distinct ligand binding sites.
UR - http://www.scopus.com/inward/record.url?scp=0344234282&partnerID=8YFLogxK
U2 - 10.1016/j.str.2003.11.001
DO - 10.1016/j.str.2003.11.001
M3 - Article
C2 - 14656437
AN - SCOPUS:0344234282
SN - 0969-2126
VL - 11
SP - 1527
EP - 1535
JO - Structure
JF - Structure
IS - 12
ER -